Immediate Impact

5 from Science/Nature 67 standout
Sub-graph 1 of 20

Citing Papers

Luminescent Lanthanides in Biorelated Applications: From Molecules to Nanoparticles and Diagnostic Probes to Therapeutics
2025 Standout
Catalytic Asymmetric Construction of Chiral Polysubstituted 3-Azabicyclo[3.1.1]heptanes by Copper-Catalyzed Stereoselective Formal [4π+2σ] Cycloaddition
2024 Standout
2 intermediate papers

Works of Suzanne Leijen being referenced

Phase I/II study with ruthenium compound NAMI-A and gemcitabine in patients with non-small cell lung cancer after first line therapy
2014
Phase I Dose-Escalation Study of the Safety, Pharmacokinetics, and Pharmacodynamics of the MEK Inhibitor RO4987655 (CH4987655) in Patients with Advanced Solid Tumors
2012

Author Peers

Author Last Decade Papers Cites
Suzanne Leijen 720 760 227 19 1.2k
Terence R. Jones 397 663 202 37 1.0k
Victoria J. Spanswick 460 906 267 39 1.3k
G. Mangold 436 657 182 46 1.2k
Masashi Aonuma 867 1152 127 14 1.5k
Franco Zunino 756 612 271 29 1.3k
R F Ozols 719 605 81 29 1.4k
F. Zunino 505 563 119 33 1.2k
Rooha Contractor 464 863 212 23 1.3k
Andreas Menrad 505 673 76 30 1.5k
Lorraine A. Cazenave 843 547 111 7 1.3k

All Works

Loading papers...

Rankless by CCL
2026